Atai Life Sciences N.V.
NASDAQ:ATAI
1.28 (USD) • At close December 27, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2023 | 2022 | 2021 | 2020 | 2019 | |
---|---|---|---|---|---|
Operating Activities: | |||||
Net Income
| -40.224 | -157.417 | -174.244 | -178.625 | -24.384 |
Depreciation & Amortization
| 0.319 | 0.168 | 0.047 | 0.024 | 0.006 |
Deferred Income Tax
| 0 | 5.074 | 39.135 | 56.346 | 7.536 |
Stock Based Compensation
| 32.982 | 42.375 | 63.362 | 67.158 | 0.057 |
Change In Working Capital
| 7.469 | -3.335 | -7.604 | 4.45 | -0.126 |
Accounts Receivables
| 0 | 0 | 0 | 0 | 0 |
Inventory
| 0 | 0 | 0 | 0 | 0 |
Accounts Payables
| 2.138 | -3.034 | 2.3 | 1.704 | 0.249 |
Other Working Capital
| 5.331 | -0.301 | -9.904 | 2.746 | -0.375 |
Other Non Cash Items
| -84.664 | 8.668 | 16.058 | 29.881 | 9.065 |
Operating Cash Flow
| -84.118 | -104.467 | -63.246 | -20.766 | -7.846 |
Investing Activities: | |||||
Investments In Property Plant And Equipment
| -0.59 | -1.024 | -1.128 | -0.059 | -0.019 |
Acquisitions Net
| -0.443 | 0 | -52.937 | -2.088 | -0.456 |
Purchases Of Investments
| -185.262 | -309.658 | -23.658 | -23.92 | -11.55 |
Sales Maturities Of Investments
| 139.469 | 226.834 | -0.955 | 0 | 10.313 |
Other Investing Activites
| -6.469 | -3 | -2.598 | -2.204 | -7.319 |
Investing Cash Flow
| -53.295 | -86.848 | -81.276 | -28.271 | -9.031 |
Financing Activities: | |||||
Debt Repayment
| 0 | 15 | 1.588 | 32.503 | 0 |
Common Stock Issued
| 0.225 | 4.636 | 409.884 | 82.439 | 42.684 |
Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 |
Dividends Paid
| 0 | 0 | 0 | 0 | 0 |
Other Financing Activities
| -8.355 | 5.785 | -1.61 | -1.89 | -2.295 |
Financing Cash Flow
| -8.355 | 20.785 | 409.862 | 113.052 | 40.389 |
Other Information: | |||||
Effect Of Forex Changes On Cash
| 0.189 | -1.123 | -0.32 | 3.169 | -0.372 |
Net Change In Cash
| -145.579 | -171.653 | 265.02 | 67.184 | 23.14 |
Cash At End Of Period
| 45.034 | 190.613 | 362.266 | 97.246 | 30.062 |